Pang, T.C.Y.; Xu, Z.; Mekapogu, A.R.; Pothula, S.; Becker, T.; Corley, S.; Wilkins, M.R.; Goldstein, D.; Pirola, R.; Wilson, J.;
et al. HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer. Cancers 2021, 13, 2763.
https://doi.org/10.3390/cancers13112763
AMA Style
Pang TCY, Xu Z, Mekapogu AR, Pothula S, Becker T, Corley S, Wilkins MR, Goldstein D, Pirola R, Wilson J,
et al. HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer. Cancers. 2021; 13(11):2763.
https://doi.org/10.3390/cancers13112763
Chicago/Turabian Style
Pang, Tony C. Y., Zhihong Xu, Alpha Raj Mekapogu, Srinivasa Pothula, Therese Becker, Susan Corley, Marc R. Wilkins, David Goldstein, Romano Pirola, Jeremy Wilson,
and et al. 2021. "HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer" Cancers 13, no. 11: 2763.
https://doi.org/10.3390/cancers13112763
APA Style
Pang, T. C. Y., Xu, Z., Mekapogu, A. R., Pothula, S., Becker, T., Corley, S., Wilkins, M. R., Goldstein, D., Pirola, R., Wilson, J., & Apte, M.
(2021). HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer. Cancers, 13(11), 2763.
https://doi.org/10.3390/cancers13112763
